Electrodiagnosis

The Worldwide Wireless Electrocardiography Device Industry is Expected to Reach $2.2+ Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 6, 2021

Wireless Electrocardiography (ECG) Devices Market Analysis, By Type

Key Points: 
  • Wireless Electrocardiography (ECG) Devices Market Analysis, By Type
    Chapter 6.
  • Wireless Electrocardiography (ECG) Devices Market Analysis, By Modality
    Chapter 8.
  • Wireless Electrocardiography (ECG) Devices Market Analysis, By End User
    Chapter 9.
  • Wireless Electrocardiography (ECG) Devices Market Analysis, By Country
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210906005054/en/

Assure Holdings Performs First Neuromonitoring Case in Nebraska

Retrieved on: 
Thursday, July 29, 2021

DENVER, July 29, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that it has performed its first neuromonitoring case in the state of Nebraska.

Key Points: 
  • DENVER, July 29, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that it has performed its first neuromonitoring case in the state of Nebraska.
  • Assure is continuing to generate strong organic growth, both by expanding into new states and extending our reach within our current operational footprint.
  • Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.
  • Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned The Joint Commissions Gold Seal of Approval.

Dominican Republic National Baseball Team Turns to STRIVE to Optimize Performance at the Tokyo Olympic Games

Retrieved on: 
Tuesday, July 27, 2021

STRIVE , the only platform proven to optimize muscle performance for elite athletes and teams, today announced that the Dominican Republics national baseball team has been using the STRIVE platform during training for the Olympic Games in Tokyo, Japan.

Key Points: 
  • STRIVE , the only platform proven to optimize muscle performance for elite athletes and teams, today announced that the Dominican Republics national baseball team has been using the STRIVE platform during training for the Olympic Games in Tokyo, Japan.
  • STRIVE has enabled the teams training staff to monitor players muscle performance in all active settings in the lead-up to the 2021 Olympic Games: practice, conditioning, and in-game.
  • The STRIVE platform gives us technology to add value to the players understanding of their body.
  • STRIVEs world-leading electromyography (EMG) technology enables the Dominican national team to monitor the muscle activation of its players hamstrings, glutes, and quadriceps.

Insights on the Single Lead ECG Equipment Global Market to 2027 - Featuring AliveCor, Contec Medical Systems and Eurocamina Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, July 23, 2021

The "Single Lead ECG Equipment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Single Lead ECG Equipment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Syncope, one of the segments analyzed in the report, is projected to record a 4.3% CAGR and reach US$216.7 Million by the end of the analysis period.
  • The U.S. Market is Estimated at $100.6 Million, While China is Forecast to Grow at 7.3% CAGR
    The Single Lead ECG Equipment market in the U.S. is estimated at US$100.6 Million in the year 2020.
  • In the global Other Indications segment, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this segment.

ECG Surpasses $500 Million in Fundings

Retrieved on: 
Wednesday, July 7, 2021

Expansion Capital Group today announced it has surpassed over $500 million in fundings provided to small businesses.

Key Points: 
  • Expansion Capital Group today announced it has surpassed over $500 million in fundings provided to small businesses.
  • In 2020, ECG introduced a rebranding campaign called Lets Get Growing which has reflected the companys evolution and growth.
  • ECG is a technology-enabled specialty lender that leverages data and analytics to offer customized solutions for small businesses.
  • Thanks to the speed at which ECGs technology and analytics platform serves its customers, ECG has continuously grown, providing approximately $500 million in working capital to over 15,000 small businesses throughout the United States.

Assure Sets Monthly Record for Cash Collection and Procedures in June 2021

Retrieved on: 
Tuesday, July 6, 2021

DENVER, July 06, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), announced a monthly record for cash collection and number of procedures during June 2021.

Key Points: 
  • DENVER, July 06, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), announced a monthly record for cash collection and number of procedures during June 2021.
  • Results and expectations relating to billing and collections include:
    The Company collected a monthly record $2.7 million in June 2021.
  • Based upon recent discussions with various insurance providers, Assure expects to continue the strong trend of collections in 2021.
  • Farlinger concluded, The Company reported more than 1,600 cases in June 2021, our highest number of monthly procedures ever.

Adept Neuro Reaches Key Milestone in the Development of Novel Intracerebral Stereoelectroencephalography (SEEG) Electrodes

Retrieved on: 
Tuesday, July 6, 2021

DIXI Medical will be investing its second tranche into Adept Neuro well ahead of the previously scheduled date, as per its development agreement.

Key Points: 
  • DIXI Medical will be investing its second tranche into Adept Neuro well ahead of the previously scheduled date, as per its development agreement.
  • Adept Neuro is a joint venture between DIXI Medical and Aleva Neurotherapeutics developing a new generation of intracerebral stereoelectroencephalography (SEEG) electrodes to facilitate localization and thermocoagulation of epileptogenic zones.
  • The DIXI Medical story started back in the 1970s with the request from French physicians to develop dedicated electrodes for SEEG surgeries.
  • Over 40 years later, DIXI Medical still has the same focus on epilepsy care and SEEG electrodes.

Assure Holdings Supports Rare Auditory Brainstem Implant Surgery

Retrieved on: 
Thursday, June 24, 2021

DENVER, June 24, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that it supported a successful auditory brainstem implant surgery.

Key Points: 
  • DENVER, June 24, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that it supported a successful auditory brainstem implant surgery.
  • The auditory brainstem implant surgery was performed to restore hearing in a patient who had lost this function.
  • In addition, neurophysiologists monitored all associated lower cranial nerves, minimizing the potential negative side effects of the implant.
  • Assure Neuromonitoring was a critical part of the team allowing us to successfully complete the auditory brainstem implant procedure, said Dr. Moises Arriaga.

Cardiac Insight Announces 4th Generation of Its Cardea SOLO™ ECG Monitoring System

Retrieved on: 
Tuesday, June 22, 2021

The Company announces continued innovation with new software advancements for its Cardea SOLO ECG System (Cardea SOLO).

Key Points: 
  • The Company announces continued innovation with new software advancements for its Cardea SOLO ECG System (Cardea SOLO).
  • The Cardea SOLO wearable single-use ECG sensor is typically applied to the patient in a hospital, clinic or physicians office.
  • It can also be shipped directly to the patient for easy in-home application through Cardiac Insights Cardea SOLO convenient telehealth program.
  • The companys products include the Cardea SOLO wearable ECG Sensor and Software Analysis System, and the Cardea 20/20 ECG the only resting ECG System designed for cardiac risk screening in young athletes at all levels of play.

Over $700 Million growth expected in EEG and EMG Devices Market during 2021-2025 | Technavio

Retrieved on: 
Monday, June 21, 2021

The EEG and EMG devices market is expected to grow by USD 706.20 million during 2021-2025, according to Technavio.

Key Points: 
  • The EEG and EMG devices market is expected to grow by USD 706.20 million during 2021-2025, according to Technavio.
  • The EEG and EMG devices market will witness a positive impact during the forecast period owing to the widespread growth of the COVID-19 pandemic.
  • Gain more insights about the global trends impacting the future of EEG and EMG devices market, Request Free Sample @ https://www.technavio.com/talk-to-us?report=IRTNTR40609
    Major Five EEG and EMG Devices Market Participants:
    Ambu AS:The company offers EEG and EMG equipment under the brand names Ambu Neuroline Cup, Ambu Neuroline Monopolar electrodes, Ambu Neuroline Concentric, and Ambu Neuroline 715.
  • EEG and EMG Devices Market 2021-2025: Segmentation
    EEG and EMG devices market is segmented as below: